secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2022-11-14T23:59:59+00:00
Accession:  0001437749-22-027079
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders elect all five director nominees and ratify Armanino as auditor at 2022 annual meeting
--------------------------------------------------------------------------------

- All five nominees (Bhat, Saxena, Margolin, Patel, Funtleyder) elected; votes for ranged from 7.8M to 8.3M.
- Ratification of Armanino LLP as auditor passed with 12,986,442 for, 11,054 against, 21,489 abstentions.
- Broker non-votes were 4,702,220 on director elections and zero on auditor ratification.
- Meeting held November 10, 2022; results filed November 14, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774922027079/0001437749-22-027079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774922027079/rvph20221111b_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-027079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer